ShammasNWMangalmurtiSBernardoNL, et alIntravascular lithotripsy for treatment of severely calcified common femoral artery disease: results from the disrupt PAD III observational study [published online ahead of print June 15, 2024]. J Endovasc Ther. doi:10.1177/15266028241255622.
2.
GouefficYDella SchiavaNThaveauF, et alStenting or surgery for de novo common femoral artery stenosis. JACC Cardiovasc Interv. 2017;10(13):1344–1354.
3.
NakamaTTakaharaMIwataY, et al1-year outcomes of thromboendarterectomy vs endovascular therapy for common femoral artery lesions: CAULIFLOWER study results. JACC Cardiovasc Interv. 2022;15(14):1453–1463.
4.
RastanABöhmeTZellerT.Percutaneous intervention versus surgery in the treatment of common femoral artery lesions: study protocol for the prospective, multi-center, randomized PESTO-CFA trial. Trials. 2024;25(1):370.
5.
BöhmeTRomanoLMacharzinaRR, et alOutcomes of directional atherectomy for common femoral artery disease. Eurointervention. 2021;17(3):260–266.
6.
SchöfthalerCTroisiNTorselloG, et alSafety and effectiveness of the phoenix atherectomy device for endovascular treatment of common femoral and popliteal arteries: results of the EN-MOBILE trial. Vasc Med. 2024;29(4):405–415.